Mirati Therapeutics
MRTX
#2868
Rank
S$5.54 B
Marketcap
$78.98
Share price
0.00%
Change (1 day)
48.62%
Change (1 year)

EPS for Mirati Therapeutics (MRTX)

EPS in 2023 (TTM): -$17.47

According to Mirati Therapeutics's latest financial reports the company's current EPS (TTM) is -$17.25. In 2022 the company made an earnings per share (EPS) of -$17.73 a decrease over its 2021 EPS that were of -$15.03.

EPS history for Mirati Therapeutics from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$17.47-1.47%
2022-$17.7317.99%
2021-$15.0340.5%
2020-$10.7040.96%
2019-$7.5977.92%
2018-$4.2713.62%
2017-$3.75-33.57%
2016-$5.6510.82%
2015-$5.1016.98%
2014-$4.36-32.19%
2013-$6.4368.77%
2012-$3.81-15.95%
2011-$4.53-81.27%
2010-$24.19-37.19%
2009-$38.52174.53%
2008-$14.03-65.27%
2007-$40.40146.72%
2006-$16.37-58.81%
2005-$39.75

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$12.81-174.26%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.08073-99.53% Bahamas